The Search Results Are the Story

This story is part of The Longevity Marketplace, our seven-part guide. Start with the full guide.

Open a search engine and type in one of the words the aging-science business runs on: senolytics, NMN, nicotinamide riboside, longevity clinic. Look at that first screen of results. It is not a reading list of studies and trials. It is a storefront.

Supplement shops, “best NMN” ranking lists, biohacker blogs with a Buy button, clinic directories. They own the top of the page. The coverage trying to sell you nothing is down where almost nobody scrolls. And that is not a fluke of one afternoon’s searching. It is the version of the science most people ever see, and it quietly decides what they come away believing.

That storefront has, for most people, taken the place of actually reading the research. Our first series, Decode Your Wellbeing, mapped the big claims and where the marketing runs out ahead of the evidence. This one goes a floor lower. It stays down in the actual human trials and the sales machine built on top of them, and it measures the gap between what you are sold and what the studies really found.

What the rankings actually look like

Search NMN, or nicotinamide mononucleotide if you want the full name, and you get page after page of retailers, a few “we ranked the best” affiliate lists, and clinic pages selling membership programs that run into the thousands of dollars. Now, results move around. They shift with your location, your search history, and the day, so take this as what we saw when we looked, not a law of physics. But the direction does not really change.

And the ranking is not neutral. Search engines reward things like backlinks, fresh copy, and a slick page, and a well-funded store produces all of that far better than a page that just reports what a trial found. The retailer has a budget to build links and refresh the copy every week. The trial sits in a journal and does nothing of the kind. So the commercial version of the science ends up in front of far more people than the real research ever will.

Why independent coverage is scarce

Doing this the careful way is slow, and it is not cheap. Reading a Phase 1 or Phase 2 trial, digging out the real dose, how many people were actually in it, what the study was measuring, and where it fell short, then turning all of that into plain English, takes hours and someone who knows how to read a study. Most sites cannot afford that, so they skip it.

The money runs the other way, too. One “best NMN of 2026” list with affiliate links can earn a cut on every bottle it sends out the door, month after month, while an honest breakdown of a trial earns you nothing but a little trust. Guess which one gets made ten times over.

The rules widen the gap even further. A prescription drug has to prove itself before it can be sold. A supplement does not. Under a 1994 law, the Dietary Supplement Health and Education Act, a company can put a longevity pill on the shelf first and answer questions later, as long as it phrases the promise carefully, “supports healthy aging,” and prints the little line that the FDA has not evaluated any of it. That gray zone is what lets so much sales copy exist in the first place, all of it fighting for the same top spot.

The distortion effect

When the loudest information about a science comes from the people selling it, the same few distortions show up again and again.

The first thing to blur is the difference between moving a number and actually helping you. Raising the NAD+ level in your blood is real and easy to measure. Getting your muscles, your blood sugar, or your memory to work better is a much bigger, and completely separate, claim. Sales copy loves to treat the easy one as if it proves the hard one.

Then a small, early hint gets dressed up as settled fact. What you rarely see in the copy is the missing part: there still isn’t a big, well-run, placebo-controlled trial showing the pill does anything you can actually feel. The difference between a dose given under a doctor’s eye in a study and a capsule you grab off a shelf disappears in a single sentence. And “we saw no problems over a few weeks” quietly becomes “safe to take for years.”

What this series will do

The rest of this series stays down in that real evidence and the sales machine built over it. Part 2 explains senescence, the so-called zombie cells, in plain terms so the trial talk later actually lands. Part 3 walks through the real human trials of senolytics: what was tested, on how many people, and what came back. Part 4 holds those trials up against the products sold under the same name. Parts 5 and 6 do the same for NAD+, NMN, and nicotinamide riboside, the biology, the recent crack in the tidy “it just declines with age” story, and what the human studies actually show. Part 7 ends where the money does, at the longevity clinic.

None of these pieces will tell you what to buy or crown a best brand. The job is smaller than that, and we think more useful: pull the actual research and the sales machinery into the open, so you can weigh a claim with something better than a page of ads. The search results were never a clean window onto the science. Seeing them for what they are is where thinking for yourself starts.

Built against current standards generation: E.G. v4.16 · I.R.G. v1.13 · L.R.G. v1.9 · P.L.G. v1.10 · SEO G. v1.5 · Publishing Checklist v1.4 · AI Detection Gate v1.0. As of August 2026.